<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Di Carli, Marcelo</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Hypertension and the Foundation of Antihypertensive Therapy</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-09-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">21-22</style></pages><abstract><style  face="normal" font="default" size="100%">Significant advances have been made in the recognition and diagnosis of hypertension, but many patients have not achieved blood pressure control at levels that reduce cardiovascular risk. This article discusses the current state of antihypertensive therapy, compliance, and angiotensin receptor blockers.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>